SEC 13F Intelligence

Altium Capital Management LLC / SKYE

Altium Capital Management LLC’s Skye Bioscience Inc Position

Does Altium Capital Management LLC own Skye Bioscience Inc (SKYE)? Not currently — the last reported position was 904.9K shares worth $1M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$1M
Q1 2025
Shares
904.9K
% of Portfolio
+3.47%
Quarters Held
4
position exited

Position History SKYE

Reported value by quarter
Q2 ’24: $11MQ2 ’24Q3 ’24: $5MQ3 ’24Q4 ’24: $3MQ4 ’24Q1 ’25: $1MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2025904.9K$1M+3.47%
Q4 20241.14M$3M+0.91%
Q3 20241.32M$5M+1.51%
Q2 20241.35M$11M+4.41%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of SKYE.